Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02556931
Title Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center

myeloproliferative neoplasm

chronic lymphocytic leukemia/small lymphocytic lymphoma

prolymphocytic leukemia

myelodysplastic syndrome

plasma cell neoplasm

chronic myeloid leukemia


Cyclophosphamide + Fludarabine + Melphalan + Tacrolimus

Age Groups: adult | child | senior
Covered Countries USA

No variant requirements are available.